Covered recipient · General Payments record
ANALI J RINCON
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2022–2024
$1,300.07
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $595.85 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $344.52 | 4 |
| Amgen Inc. | $175.97 | 5 |
| GlaxoSmithKline, LLC. | $49.10 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $26.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.09 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117365083 | CMS |
| Amgen Inc. | $124.99 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111688466 | CMS |
| Amgen Inc. | $14.84 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117365085 | CMS |
| Amgen Inc. | $8.50 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117365087 | CMS |
| Amgen Inc. | $11.55 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117365089 | CMS |
| AstraZeneca Pharmaceuticals LP | $10.38 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104560822 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105634528 | CMS |
| AstraZeneca Pharmaceuticals LP | $84.14 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104660189 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105824307 | CMS |
| Boston Scientific Corporation | $26.26 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092446412 | CMS |
| GlaxoSmithKline, LLC. | $23.82 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116459177 | CMS |
| GlaxoSmithKline, LLC. | $25.28 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116199320 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.